Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Colorcon
Harvard Business School
Citi
McKinsey
Cerilliant
US Army
Merck

Generated: May 25, 2018

DrugPatentWatch Database Preview

Vidarabine - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for vidarabine and what is the scope of vidarabine patent protection?

Vidarabine
is the generic ingredient in one branded drug marketed by Parkedale and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for vidarabine.
Summary for vidarabine
Medical Subject Heading (MeSH) Categories for vidarabine
Synonyms for vidarabine
(+)-Cyclaradine
(2R,3S,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
(2R,3S,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
2-(6-Amino-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
3XQD2MEW34
536V174
5536-17-4
6-amino-9-(beta-D-arabinofuranosyl)purine
6-Amino-9-b-D-arabinofuranosylpurine
6-Amino-9-beta-D-arabinofuranosylpurine
9--D-arabinofuranosyl-9H-purin-6-amine
9-.beta.-D-Arabinofuranosyl-9H-purine-6-amine
9-(b-D-Arabinofuranosyl)adenine
9-(beta-D-arabinofuranosyl)-9H-adenine
9-Arabinosyladenine
9-beta-Arabinoadenosine
9-beta-Arabinofuranosyladenine
9-beta-D-arabinofuranosyl adenine
9-beta-D-arabinofuranosyl-9H-purin-6-amine
9-beta-D-Arabinofuranosyl-9H-purin-6-amine (9CI)
9-BETA-D-ARABINOFURANOSYL-ADENINE
9-beta-D-Arabinofuranosyladenine
9beta-D-Arabinofuranosyladenine
9H-adenin-9-yl beta-D-arabinofuranoside
9H-Purin-6-amine, 9- beta-D-arabinofuranosyl-
9H-Purin-6-amine, 9-.beta.-D-arabinofuranosyl-
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-
9H-Purin-6-amine, 9beta-D-arabinofuranosyl-
A 9251
AB00430250_11
AB00430250_12
AB00430250-08
AB00430250-09
AB2000291
AC1L2IWM
Adenine 9-beta-D-arabinofuranoside
Adenine 9-beta-D-arabinofuranoside, >=99%
Adenine 9-beta;-D-arabinofuranoside
Adenine arabinoside
Adenine beta-D-arabinofuranoside
Adenine xyloside
Adenine-9-beta-D-arabinofuranoside
Adenine-beta-D-arabinofuranoside
adenine-D-ribose
Adenine, 9-beta-D-arabinofuranosyl-
Adenine, 9beta-D-arabinofuranosyl-
Adenocard, Adenosine
Adenosine arabinose
Adenosine-8-14C
ADENOSINE, U.S.P.
AI3-52821
AJ-24609
AK-54743
AKOS015919711
alpha-Ara A
alpha-D-Arabinofuranosyladenine
Ambap5536-17-4
ANW-46947
Ara A
Ara-A
ARA-A NSC 247519
araA
Araadenosine
Arabinofuranosyladenine
Arabinoside adenine
Arabinosyl adenine
Arabinosyl-adenine
Arabinosyladenine
Arasena-A
Armes
Armes (TN)
AX8042581
BDBM50144936
beta-Ara A
beta-D-Arabinofuranosyladenine
beta-D-Arabinosyladenine
BR-54743
BRN 0624881
BSPBio_002000
CCG-39634
CCRIS 3383
CHEBI:45327
CHEMBL1090
CI 673
CI-673
CJ-04655
CPD000471872
CS-2267
CTK8B4983
D06298
D0NI0C
DB00194
DivK1c_000191
DS-1755
EINECS 226-893-9
GTPL4806
HG1001
HMS1921K05
HMS2090F06
HMS2092C16
HMS2230N24
HMS3259I08
HMS500J13
HSDB 6514
HY-B0277
IDI1_000191
KB-46926
KBio1_000191
KBio2_002418
KBio2_004986
KBio2_007554
KBio3_001500
KBioGR_001224
KBioSS_002424
KSC914S8H
LS-15059
MFCD00065471
MLS001066352
MLS001333133
MLS001333134
MolPort-003-666-308
NC00547
NCGC00023673-08
NCGC00178869-01
NINDS_000191
NSC 247519
NSC-404241
NSC-757383
NSC247519
NSC757383
OIRDTQYFTABQOQ-UHTZMRCNSA-N
PDSP1_001036
PDSP2_001020
Pharmakon1600-01500609
RAB
RTR-019519
S-5624
s1784
SAM002564191
SBI-0051555.P002
SC-17048
SCHEMBL110914
SMP1_000312
SMR000471872
SPBio_001491
Spectrum_001894
SPECTRUM1500609
Spectrum2_001336
Spectrum3_000580
Spectrum4_000782
Spectrum5_001429
Spongoadenosine
SR-01000765435
SR-01000765435-2
ST2412176
UNII-3XQD2MEW34
Vidarabin
Vidarabina
Vidarabina [DCIT]
Vidarabine (anhydrous)
Vidarabine (JAN)
Vidarabine (Vira-A)
Vidarabine [INN]
Vidarabine anhydrous
Vidarabine, United States Pharmacopeia (USP) Reference Standard
Vidarabinum
Vidarabinum [INN-Latin]
Vira ATM
Vira-A
Vira-A, Vidarabine
VIRDARABINE
Xylosyl A
Xylosyladenine
ZB015567
ZINC970363

US Patents and Regulatory Information for vidarabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parkedale VIRA-A vidarabine INJECTABLE;INJECTION 050523-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale VIRA-A vidarabine OINTMENT;OPHTHALMIC 050486-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Department of Justice
Daiichi Sankyo
Farmers Insurance
Express Scripts
Baxter
Queensland Health
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.